Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 5:02 PM ET

Biotechnology

Company Overview of Novelos Therapeutics, Inc.

Company Overview

As of April 8, 2011, Novelos Therapeutics, Inc. was acquired by Cellectar, Inc., in a reverse merger transaction. Novelos Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis in the United States. Its development product line primarily includes NOV-002, a phase II injectable small-molecule compound, which acts as a chemopotentiator and a chemoprotectant and that is being developed for use in combination with standard of care chemotherapies for the treatment of solid tumors. The NOV-002 is also being developed and is in phase II clinical trial to treat early-stage breast cancer...

One Gateway Center

Suite 504

Newton, MA 02458

United States

Founded in 1996

12 Employees

Phone:

617-244-1616

Fax:

617-964-6331

Key Executives for Novelos Therapeutics, Inc.

Novelos Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Armed, L.L.C. United States
HDSono, Inc. United States
Viridus Animal Health, LLC United States
RadioMedix, Inc. United States
Advanced Microbotics Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novelos Therapeutics, Inc., please visit www.novelos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.